CLINICAL_TRIALS
trial_result
· 2017-08-31
Clinical Trial Update: Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing Surgery [Phase 3]
Summary
A Phase 3 trial evaluating recombinant von Willebrand factor in patients with severe von Willebrand disease undergoing surgery has completed, with results poste…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baxalta now part of Shire | Conditions: Von Willebrand Disease | Phase 3 | Status: COMPLETED | Results posted: 2017-08-31